Patient‐Reported Swallowing Outcomes in HPV+ Oropharyngeal Cancer by Postoperative Chemoradiation Dose in MINT and E3311
Theresa Tharakan(Washington University in St. Louis), Ryan S. Jackson(Washington University in St. Louis), Sidharth V. Puram(Washington University in St. Louis), Anthony J. Apicelli(Washington University in St. Louis), R. Alex Harbison(Washington University in St. Louis), Douglas Adkins(Washington University in St. Louis), Patrik Pipkorn(Washington University in St. Louis), Randal C. Paniello(Washington University in St. Louis), Michael J. Moravan(Duke Medical Center), Wade L. Thorstad(Washington University in St. Louis), Mena Mansour(The University of Texas MD Anderson Cancer Center), Hiram A. Gay(Washington University in St. Louis), Paul Zolkind(Washington University in St. Louis), Jessica Ley(Washington University in St. Louis), Peter Oppelt(Washington University in St. Louis), Rebecca D. Chernock(Washington University in St. Louis)
Cited by 2
Related Papers
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
|Cell|2017|2.6k
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
|Nature Genetics|2020|465
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
|Clinical Cancer Research|2020|372
High-Risk Human Papillomavirus E6/E7 mRNA Detection by a Novel In Situ Hybridization Assay Strongly Correlates With p16 Expression and Patient Outcomes in Oropharyngeal Squamous Cell Carcinoma
|The American Journal of Surgical Pathology|2011|292